SCHEMBL1796173

SCHEMBL1796173

N#Cc1cc(Cl)ccc1[N]C(=O)COCC(=O)N1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.55
SERPINE1 P05121 1/20 0.55
CACNA2D1 P54289 11/20 0.51
CACNB1 Q02641 11/20 0.51
CACNA1B Q00975 10/20 0.51
CACNA1C Q13936 6/20 0.51
CACNA1G O43497 4/20 0.51
CACNA1A O00555 1/20 0.48
CACNA1H O95180 1/20 0.43
HRH1 P35367 2/20 0.43
SLC6A2 P23975 1/20 0.43
HRH2 P25021 1/20 0.43
HTR2A P28223 1/20 0.43
SLC6A4 P31645 1/20 0.43
DRD3 P35462 1/20 0.43
HTR2B P41595 1/20 0.43
SLC6A3 Q01959 1/20 0.43
TEK Q02763 1/20 0.43
KCNH2 Q12809 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796175 0.82 SERPINE1 (0.75) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL1800358 0.79 SERPINE1 (0.52) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL7665618 0.79 NPC1 (0.78) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL1446803 0.76 NPC1 (0.85) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL1446552 0.76 NPC1 (0.85) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL15703692 0.75 NPC1 (0.71) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL1446717 0.75 NPC1 (0.71) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL15703563 0.73 CACNA2D1 (0.65) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL15703562 0.73 CACNA2D1 (0.65) NPC1SERPINE1CACNA2D1CACNB1CACNA1B
SCHEMBL4277286 0.71 NPSR1 (0.68) NPC1SERPINE1CACNA2D1CACNB1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 NPC1 1319/4885SERPINE1 1/4885CACNA2D1 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.